BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21284954)

  • 1. Quinpirole-induced sensitization to noisy/sparse periodic input: temporal synchronization as a component of obsessive-compulsive disorder.
    Gu BM; Cheng RK; Yin B; Meck WH
    Neuroscience; 2011 Apr; 179():143-50. PubMed ID: 21284954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral pattern analysis and dopamine release in quinpirole-induced repetitive behavior in rats.
    de Haas R; Nijdam A; Westra TA; Kas MJ; Westenberg HG
    J Psychopharmacol; 2011 Dec; 25(12):1712-9. PubMed ID: 21148023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder.
    Dvorkin A; Perreault ML; Szechtman H
    Behav Brain Res; 2006 May; 169(2):303-11. PubMed ID: 16524632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked inbred mouse strain difference in the expression of quinpirole induced compulsive like behavior based on behavioral pattern analysis.
    de Haas R; Seddik A; Oppelaar H; Westenberg HG; Kas MJ
    Eur Neuropsychopharmacol; 2012 Sep; 22(9):657-63. PubMed ID: 22326620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-frequency stimulation of the nucleus accumbens core and shell reduces quinpirole-induced compulsive checking in rats.
    Mundt A; Klein J; Joel D; Heinz A; Djodari-Irani A; Harnack D; Kupsch A; Orawa H; Juckel G; Morgenstern R; Winter C
    Eur J Neurosci; 2009 Jun; 29(12):2401-12. PubMed ID: 19490027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features of compulsive checking behavior mediated by nucleus accumbens and orbital frontal cortex.
    Dvorkin A; Silva C; McMurran T; Bisnaire L; Foster J; Szechtman H
    Eur J Neurosci; 2010 Nov; 32(9):1552-63. PubMed ID: 20731708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compulsive-like effects of quinpirole on drinking behavior in rats are inhibited by substituting ethanol for water.
    Amato D; Milella MS; Badiani A; Nencini P
    Behav Brain Res; 2007 Feb; 177(2):340-6. PubMed ID: 17157931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociable dopaminergic and pavlovian influences in goal-trackers and sign-trackers on a model of compulsive checking in OCD.
    Eagle DM; Schepisi C; Chugh S; Desai S; Han SYS; Huang T; Lee JJ; Sobala C; Ye W; Milton AL; Robbins TW
    Psychopharmacology (Berl); 2020 Dec; 237(12):3569-3581. PubMed ID: 32886158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinpirole-induced behavioral sensitization is enhanced by prior scheduled exposure to sucrose: A multi-variable examination of locomotor activity.
    Foley KA; Fudge MA; Kavaliers M; Ossenkopp KP
    Behav Brain Res; 2006 Feb; 167(1):49-56. PubMed ID: 16198008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal immune system activation with lipopolysaccharide enhances behavioural sensitization to the dopamine agonist, quinpirole, in adult female but not male rats.
    Tenk CM; Foley KA; Kavaliers M; Ossenkopp KP
    Brain Behav Immun; 2007 Oct; 21(7):935-45. PubMed ID: 17449223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hypophysectomy on compulsive checking and cortical dendrites in an animal model of obsessive-compulsive disorder.
    Dvorkin A; Culver KE; Waxman D; Szechtman H; Kolb B
    Behav Pharmacol; 2008 Jul; 19(4):271-83. PubMed ID: 18622174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole.
    Einat H; Szechtman H
    Physiol Behav; 1995 Jan; 57(1):55-9. PubMed ID: 7878126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compulsive-like effects of repeated administration of quinpirole on drinking behavior in rats.
    Amato D; Milella MS; Badiani A; Nencini P
    Behav Brain Res; 2006 Sep; 172(1):1-13. PubMed ID: 16677719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole.
    Jung TD; Jung PS; Raveendran L; Farbod Y; Dvorkin-Gheva A; Sakic B; Surette MG; Szechtman H
    Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):211-224. PubMed ID: 29194070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age differences in an animal model of obsessive-compulsive disorder: participation of dopamine: dopamine in an animal model of OCD.
    Ulloa RE; Nicolini H; Fernández-Guasti A
    Pharmacol Biochem Behav; 2004 Aug; 78(4):661-6. PubMed ID: 15301919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of riluzole and memantine on learning deficit following quinpirole sensitization - An animal model of obsessive-compulsive disorder.
    Janikova M; Brozka H; Radostova D; Svoboda J; Stuchlik A
    Physiol Behav; 2019 May; 204():241-247. PubMed ID: 30826389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic control of food choice: contrasting effects of SKF 38393 and quinpirole on high-palatability food preference in the rat.
    Cooper SJ; Al-Naser HA
    Neuropharmacology; 2006 Jun; 50(8):953-63. PubMed ID: 16549074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.